SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : NKTR Drug delivery Company
NKTR 19.77-6.5%3:59 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: Miljenko Zuanic11/10/2019 11:37:02 AM
   of 508
 
RE: NKTR358 (@ACR)
PR: finance.yahoo.com
Poster: nektar.com
< subcutaneous doses of NKTR-358 ranging from 0.3 to 28.0 µg/kg and were followed for 50 days after dosing.>

Visible dose response curve.

Wish they did bumped 214 doses up to 20mcg/kg and eliminate/reduce all this BS (and uncertainty) around 214!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext